Investigational Site Number : 3560002

Nashik 422101

0 studies enrolling now · 1 studies all time

What they study most

Dermatitis Atopic

Studies at this site

• Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis — Running, not enrolling